Compile Data Set for Download or QSAR
maximum 50k data
Found 56 Enz. Inhib. hit(s) with all data for entry = 50027790
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246925(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3-methyl...)
Affinity DataKi:  200nMAssay Description:Binding affinity to human vasopressin V2 receptor expressed in HEK293 cells by radioligand binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246575(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataKi:  2.00E+3nMAssay Description:Binding affinity to human vasopressin V2 receptor expressed in HEK293 cells by radioligand binding assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOxytocin receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246575(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to oxytocin receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOxytocin receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246890(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]benzoyl)-...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to oxytocin receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetOxytocin receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246925(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3-methyl...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to oxytocin receptor (unknown origin)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246642(4,4-Difluoro-1-(2-methyl-4-(2,3,4,5-tetrahydro-1-b...)
Affinity DataEC50:  50nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246643(4,4-Dimethoxy-1-(2-methyl-4-(2,3,4,5-tetrahydro-1-...)
Affinity DataEC50:  20nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246644(1-(4-(5-Hydroxy-2,3,4,5-tetrahydro-1-benzazepin-1-...)
Affinity DataEC50:  230nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246645(1-(2-Methyl-4-(5-methyl-2,3,4,5-tetrahydro-1-benza...)
Affinity DataEC50:  220nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246719(1-(4-(5,5-Difluoro-2,3,4,5-tetrahydro-1-benzazepin...)
Affinity DataEC50:  1.70E+3nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246720(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1,5-benzoxazepin...)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246721(1-(4-(10,11-Dihydro-5H-pyrrolo[2,1-c][1,4]benzodia...)
Affinity DataEC50:  120nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246722(1-(4-(6,7-Dihydro-5H-dibenzo[b,d]azepin-5-ylcarbon...)
Affinity DataEC50:  84nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246765(1-(4-(6,7-Dihydro-5H-pyrrolo[1,2-a][1,5]benzodiaze...)
Affinity DataEC50:  140nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246925(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3-methyl...)
Affinity DataEC50:  13nMAssay Description:Agonist activity at rat vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase reporter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246609((4R)-4-Ethoxy-1-(2-methyl-4-(2,3,4,5-tetrahydro-1-...)
Affinity DataEC50:  15nMAssay Description:Agonist activity at rat vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase reporter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246608((4R)-4-Methoxy-1-(2-methyl-4-(2,3,4,5-tetrahydro-1...)
Affinity DataEC50:  65nMAssay Description:Agonist activity at rat vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase reporter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246596((4R)-4-Hydroxy-1-(2-methyl-4-(2,3,4,5-tetrahydro-1...)
Affinity DataEC50:  41nMAssay Description:Agonist activity at rat vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase reporter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246575(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  150nMAssay Description:Agonist activity at rat vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase reporter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Vantia

Curated by ChEMBL
LigandPNGBDBM50240946(1-(4-[N-(2-dimethylamino-2-oxoethylcarbamoyl)amino...)
Affinity DataEC50:  50nMAssay Description:Agonist activity at rat vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase reporter...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246958(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3-ethylb...)
Affinity DataEC50:  10nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246959(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-3,5-dime...)
Affinity DataEC50:  82nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246889(1-(4-[3-(2-Fluorophenyl)ureidomethyl]-3-methylbenz...)
Affinity DataEC50:  30nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246960(1-(4-[3-Phenylureidomethyl]-3-methylbenzoyl)-2,3,4...)
Affinity DataEC50:  130nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246961(1-(3-Methyl-4-[3-(2-oxo-1,2-dihydropyrid-3-yl)urei...)
Affinity DataEC50:  140nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247018(1-(4-[N-(Carboxymethylcarbamoyl)aminomethyl]-3-met...)
Affinity DataEC50:  180nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247019(1-(4-[N-(2-Methoxy-2-oxoethylcarbamoyl]aminomethyl...)
Affinity DataEC50:  37nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247020(1-(4-[N-(2-Ethoxy-2-oxoethylcarbamoyl)aminomethyl]...)
Affinity DataEC50:  140nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247021(1-(4-[N-(2-iso-propyloxy-2-oxoethylcarbamoyl)amino...)
Affinity DataEC50:  140nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247061(1-(4-[N-(2-tert-butyloxy-2-oxoethylcarbamoyl)amino...)
Affinity DataEC50:  120nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247062(1-(4-[N-(2-Phenoxy-2-oxoethylcarbamoyl]aminomethyl...)
Affinity DataEC50:  820nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247063(1-(4-[N-(2-Benzyloxy-2-oxoethylcarbamoyl]aminometh...)
Affinity DataEC50:  730nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247064(1-(4-[N-(2-Amino-2-oxoethylcarbamoyl)aminomethyl]-...)
Affinity DataEC50:  210nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247100(1-(4-[N-(2-Benzylamino-2-oxoethylcarbamoyl]aminome...)
Affinity DataEC50:  270nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50240946(1-(4-[N-(2-dimethylamino-2-oxoethylcarbamoyl)amino...)
Affinity DataEC50:  58nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247101(1-(4-[N-(2-Pyrrolidin-1-yl-2-oxoethylcarbamoyl]ami...)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247102(1-(4-[N-(2-Piperidin-1-yl-2-oxoethylcarbamoyl]amin...)
Affinity DataEC50:  150nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247131(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  680nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247132(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247133(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  950nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50247134(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  390nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246575(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  24nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246576(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  350nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246577(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  380nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246578(1-(2-Methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-y...)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246596((4R)-4-Hydroxy-1-(2-methyl-4-(2,3,4,5-tetrahydro-1...)
Affinity DataEC50:  2.30nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246890(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]benzoyl)-...)
Affinity DataEC50:  47nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246922(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-2-fluoro...)
Affinity DataEC50:  180nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246923(1-(2-Chloro-4-[3-(2,6-difluorophenyl)ureidomethyl]...)
Affinity DataEC50:  40nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVasopressin V2 receptor(Homo sapiens (Human))
Vantia

Curated by ChEMBL
LigandPNGBDBM50246924(1-(4-[3-(2,6-Difluorophenyl)ureidomethyl]-2-methox...)
Affinity DataEC50:  110nMAssay Description:Agonist activity at human vasopressin V2 receptor expressed in HEK293 cells assessed as increase in intracellular cAMP level by CRE-luciferase report...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: